OneRF Ablation System
Commercial- Indications
- Epilepsy, Facial pain
Company intelligence / Profile preview
NeuroOne has achieved FDA clearance for its Evo Cortical and sEEG electrodes as well as the One RF Ablation System. The One RF Ablation System demonstrated significant clinical benefit in epilepsy patients—over 90% experienced substantial seizure reduction with some achieving seizure-free status for nine months or longer. The company’s trigeminal nerve RF ablation system targeting trigeminal neuralgia was submitted to the FDA in early 2025[5][9].
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroOne Medical Technologies.